Advertisement
Advertisement
September 6, 2023
FastWave Secures Funding for IVL Systems for Cardiovascular Calcium Treatment
September 6, 2023—FastWave Medical Inc., a medical device company incubated by Big Sky Biomedical LLC partners, announced the closure of an oversubscribed multimillion dollar private financing.
The capital will support the continued development of FastWave’s intravascular lithotripsy (IVL) systems for calcific artery disease, propelling the company’s key preclinical and clinical initiatives. Investors in the private financing included notable physician/key opinion leaders (KOLs) and medical device industry stakeholders.
Scott Nelson, Cofounder and CEO of FastWave Medical commented in the company’s press release, “Since the inception of our company, we’ve received considerable inbound interest from potential investors. But when we opened up this private placement, we were blown away by the response. This financial milestone, combined with the speed at which our engineering team is moving, underscores FastWave’s momentum in the IVL space.”
Nelson continued, “The utilization of IVL in clinical practice continues to increase and our commitment to differentiated, procedurally efficient, and cost-effective systems is unwavering. I’m thankful for our board of directors and their recognition of the significant upside for our company. In addition, I’m grateful to have such an impressive list of physician KOLs and medical device industry professionals demonstrate their confidence in our team as we aim to seize the tremendous opportunities ahead for FastWave.”
Additionally, interventional cardiologist Arthur Lee, MD, stated, “IVL is an impressive therapy and FastWave’s team is moving remarkably quickly. Their inventive IVL systems promise to fill much-needed gaps with existing technologies, and I’m excited about the prospects of treating my patients with FastWave’s devices.” Dr. Lee is an adviser with High Circle Ventures, which is an alternative investment platform that provides high net worth individuals access to venture capital and private equity opportunities in companies with groundbreaking technologies.
Advertisement
Advertisement